In order to increase compliance and improve efficacy, there is an experimental long acting exenatide once monthly injectable suspension in the pipeline. This long acting formulation is currently in phase-2 trial and has showed promising results in controlling A1C in type 2 diabetes patients….
Read More »Yearly Archives: 2011
Lixisenatide Update ADA 71st Scientific Sessions
The investigational drug Lyxumia® (lixisenatide), a once daily GLP-1 agonist, is making progress as a newer drug in this increasingly crowded class of drugs. Data from four studies of the GetGoal Phase III clinical program was presented at the ADA sessions….
Read More »Liraglutide Update ADA 71st Scientific Sessions
Adding Insulin to Metformin and Liraglutide: A New Sequence of Medication Therapy for Type-2 Diabetes Patients A new clinical study shows for the first time that the addition of long-acting insulin to the medication regimen of Metformin plus Victoza (liraglutide) allowed patients to reach an A1c goal of less-than-7% with …
Read More »Editor’s Note: Knowing Your A1c and Learning How to Use an Insulin Pen Correctly
While I was talking to a large group of employees on the west coast of Florida, I made the comment that if you are over 40 and have a family history of diabetes, overweight, hypertension or have elevated lipids, you should get an A1c test at your next physical. Apparently …
Read More »Managing Clinical Problems in Diabetes, Case Study #10: Osteomyelitis
Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. PJ was referred to the diabetes centre by a physician in the infectious diseases department of a large metropolitan hospital. Mrs. PJ is an 80-year-old woman who has had type …
Read More »Diagnosis and Management of Diabetic Eye Disease, Part 3 of 7
This week we present PART 3 of our series on the Diagnosis and Management of Diabetic Eye Disease, focusing on cataracts and keratopathy….
Read More »BYDUREON™ Receives Marketing Authorization in Europe
BYDUREON™ Receives Marketing Authorization in Europe BYDUREON showed statistically significant improvements in glycemic control based on reduction of A1C (a measure of average blood sugar over three months) between 1.5 and 1.9 percent after six months.
Read More »Major Depression Linked to Higher Risk for Heart Attack, Stroke in Diabetes
Depression affects up to one-fourth of adults with diabetes and has been linked to increased mortality in older diabetes patients. This study examined its association with deaths caused by heart attacks and strokes (cardiovascular disease). Researchers in the ACCORD trial, where depression screening was done regularly, found that major depression …
Read More »The Latest on Vitamin D: Is More Better?
Does vitamin D really help to prevent type 2 diabetes?…
Read More »Antipsychotic Drugs and Insulin Resistance in Children
Antipsychotic drugs are often given to children to treat a variety of mental health and behavioral concerns. However, treating children (ages 6-18) with many of these drugs often leads to significant weight gain. These drugs are known to increase weight, and risk for diabetes and worsen other metabolic measures in …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.